Histone H3 tail binds a unique sensing pocket in EZH2 to activate the PRC2 methyltransferase

被引:68
|
作者
Jani, Krupa S. [1 ]
Jain, Siddhant U. [2 ,3 ]
Ge, Eva J. [1 ]
Diehl, Katharine L. [1 ]
Lundgren, Stefan M. [2 ,3 ]
Mueller, Manuel M. [1 ,4 ]
Lewis, Peter W. [2 ,3 ]
Muir, Tom W. [1 ]
机构
[1] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA
[2] Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI 53715 USA
[3] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53715 USA
[4] Kings Coll London, Dept Chem, London SE1 1DB, England
基金
美国国家卫生研究院;
关键词
PRC2; methyltransferase; designer chromatin; chemical biology; WEAVER SYNDROME; METHYLATION; MUTATIONS; INHIBITION; CHROMATIN; COMPLEX; GENES; DNA; RECRUITMENT; OVERGROWTH;
D O I
10.1073/pnas.1819029116
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Enhancer of Zeste Homolog 2 (EZH2) is the catalytic subunit of Polycomb Repressor Complex 2 (PRC2), the enzyme that catalyzes monomethylation, dimethylation, and trimethylation of lysine 27 on histone H3 (H3K27). Trimethylation at H3K27 (H3K27me3) is associated with transcriptional silencing of developmentally important genes. Intriguingly, H3K27me3 is mutually exclusive with H3K36 trimethylation on the same histone tail. Disruptions in this cross-talk result in aberrant H3K27/H3K36 methylation patterns and altered transcriptional profiles that have been implicated in tumorigenesis and other disease states. Despite their importance, the molecular details of how PRC2 "senses" H3K36 methylation are unclear. We demonstrate that PRC2 is activated in cis by the unmodified side chain of H3K36, and that this activation results in a fivefold increase in the k(cat) of its enzymatic activity catalyzing H3K27 methylation compared with activity on a substrate methylated at H3K36. Using a photo-cross-linking MS strategy and histone methyltransferase activity assays on PRC2 mutants, we find that EZH2 contains a specific sensing pocket for the H3K36 methylation state that allows the complex to distinguish between modified and unmodified H3K36 residues, altering enzymatic activity accordingly to preferentially methylate the unmodified nucleosome substrate. We also present evidence that this process may be disrupted in some cases of Weaver syndrome.
引用
收藏
页码:8295 / 8300
页数:6
相关论文
共 50 条
  • [1] Ezh2, the histone methyltransferase of PRC2, regulates the balance between self-renewal and differentiation in the cerebral cortex
    Pereira, Joao D.
    Sansom, Stephen N.
    Smith, James
    Dobenecker, Marc-Werner
    Tarakhovsky, Alexander
    Livesey, Frederick J.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (36) : 15957 - 15962
  • [2] Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function
    Wan, Lixin
    Xu, Kexin
    Wei, Yongkun
    Zhang, Jinfang
    Han, Tao
    Fry, Christopher
    Zhang, Zhao
    Wang, Yao Vickie
    Huang, Liyu
    Yuan, Min
    Xia, Weiya
    Chang, Wei-Chao
    Huang, Wen-Chien
    Liu, Chien-Liang
    Chang, Yuan-Ching
    Liu, Jinsong
    Wu, Yun
    Jin, Victor X.
    Dai, Xiangpeng
    Guo, Jianfeng
    Liu, Jia
    Jiang, Shulong
    Li, Jin
    Asara, John M.
    Brown, Myles
    Hung, Mien-Chie
    Wei, Wenyi
    MOLECULAR CELL, 2018, 69 (02) : 279 - +
  • [3] EZH2, the moderator in the discussion between methyltransferases at histone H3?
    Cho, Young
    Swarnabala, Sri
    Lockey, Richard F.
    Kolliputi, Narasaiah
    JOURNAL OF CELL COMMUNICATION AND SIGNALING, 2015, 9 (01) : 77 - 79
  • [4] Exploring the role of EZH2 (PRC2) as epigenetic target
    Aier, Imlimaong
    Raj, Utkarsh
    2016 INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND SYSTEMS BIOLOGY (BSB), 2016,
  • [5] Inhibition of the Histone Lysine Methyltransferase EZH2 for the Treatment of Cancer
    Verma, Sharad K.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2015, 15 (08) : 714 - 719
  • [6] The histone lysine methyltransferase Ezh2 is required for maintenance of the intestine integrity and for caudal fin regeneration in zebrafish
    Dupret, Barbara
    Volkel, Pamela
    Vennin, Constance
    Toillon, Robert-Alain
    Le Bourhis, Xuefen
    Angrand, Pierre-Olivier
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2017, 1860 (10): : 1079 - 1093
  • [7] Cryptic RNA-binding by PRC2 components EZH2 and SUZ12
    Betancur, Juan G.
    Tomari, Yukihide
    RNA BIOLOGY, 2015, 12 (09) : 959 - 965
  • [8] Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2
    Dudakovic, Amel
    Camilleri, Emily T.
    Xu, Fuhua
    Riester, Scott M.
    McGee-Lawrence, Meghan E.
    Bradley, Elizabeth W.
    Paradise, Christopher R.
    Lewallen, Eric A.
    Thaler, Roman
    Deyle, David R.
    Larson, A. Noelle
    Lewallen, David G.
    Dietz, Allan B.
    Stein, Gary S.
    Montecino, Martin A.
    Westendorf, Jennifer J.
    van Wijnen, Andre J.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (46) : 27604 - 27617
  • [9] DNA Methylation Signature for EZH2 Functionally Classifies Sequence Variants in Three PRC2 Complex Genes
    Choufani, Sanaa
    Gibson, William T.
    Turinsky, Andrei L.
    Chung, Brian H. Y.
    Wang, Tianren
    Garg, Kopal
    Vitriolo, Alessandro
    Cohen, Ana S. A.
    Cyrus, Sharri
    Goodman, Sarah
    Chater-Diehl, Eric
    Brzezinski, Jack
    Brudno, Michael
    Ming, Luk Ho
    White, Susan M.
    Lynch, Sally Ann
    Clericuzio, Carol
    Temple, I. Karen
    Flinter, Frances
    McConnell, Vivienne
    Cushing, Tom
    Bird, Lynne M.
    Splitt, Miranda
    Kerr, Bronwyn
    Scherer, Stephen W.
    Machado, Jerry
    Imagawa, Eri
    Okamoto, Nobuhiko
    Matsumoto, Naomichi
    Testa, Guiseppe
    Iascone, Maria
    Tenconi, Romano
    Caluseriu, Oana
    Mendoza-Londono, Roberto
    Chitayat, David
    Cytrynbaum, Cheryl
    Tatton-Brown, Katrina
    Weksberg, Rosanna
    AMERICAN JOURNAL OF HUMAN GENETICS, 2020, 106 (05) : 596 - 610
  • [10] Role of the EZH2 histone methyltransferase as a therapeutic target in cancer
    Italiano, Antoine
    PHARMACOLOGY & THERAPEUTICS, 2016, 165 : 26 - 31